688358.SH
祥生医疗
SSE · Healthcare · Medical - Specialties · CN
CNY 28.04
−3.31%Year over year
Reported trailing growth
- Revenue
- -4.5%
- EBITDA
- —
- EBIT
- -15.8%
- EPS
- -11.7%
- Free cash flow
- -57.4%
- Operating cash flow
- -48.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.6%
- EBITDA
- +2.8%
- EBIT
- +3.3%
- Net income
- +3.2%
- EPS
- +3.4%
- Free cash flow
- +100.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026